mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis.
J Allergy Clin Immunol
; 147(3): 877-878, 2021 03.
Article
in English
| MEDLINE | ID: covidwho-1036582
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
RNA, Messenger
/
Mastocytosis, Systemic
/
COVID-19 Vaccines
/
SARS-CoV-2
/
COVID-19
/
Anaphylaxis
/
Mast Cells
Type of study:
Case report
Topics:
Vaccines
Limits:
Adult
/
Female
/
Humans
Language:
English
Journal:
J Allergy Clin Immunol
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS